Moderna applies for full FDA approval of its COVID-19 vaccine

If approved the vaccine will stay on U.S. markets after the pandemic is over.

Published: June 1, 2021 10:30am

Updated: June 1, 2021 11:55am

Moderna on Monday asked the Food and Drug Administration for full approval of its COVID-19 vaccine.

The move makes Moderna the second U.S. drugmaker to seek a biologics license that will allow it to market the shots directly to customers, according to CNBC.

Full approval will allow the vaccine to stay on the U.S. market once the pandemic is over. 

The Facts Inside Our Reporter's Notebook

Links

Unlock unlimited access

  • No Ads Within Stories
  • No Autoplay Videos
  • VIP access to exclusive Just the News newsmaker events hosted by John Solomon and his team.
  • Support the investigative reporting and honest news presentation you've come to enjoy from Just the News.
  • Just the News Spotlight

    Support Just the News